Evaluation of the antitumor activity of the interleukin-12/pulse interleukin-2 combination.
Wigginton
J M
JM
Biological Carcinogenesis and Development Program, SAIC Frederick, Maryland, USA.
Komschlies
K L
KL
Green
J E
JE
Cox
G W
GW
Jorcyk
C L
CL
Back
T C
TC
Franco
J L
JL
Brunda
M J
MJ
Wiltrout
R H
RH
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols; D004334:Drug Administration Schedule; D007167:Immunotherapy; D018664:Interleukin-12 / Q000008:administration & dosage*; D007376:Interleukin-2 / Q000008:administration & dosage*; D051379:Mice; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000628:therapy*; D016019:Survival Analysis
D007376:Interleukin-2; D018664:Interleukin-12